Cell Biology Cloud Computing Global Market Report 2026

The cell biology cloud computing market size has grown rapidly in recent years. It will grow from $3.98 billion in 2025 to $4.56 billion in 2026 at a compound annual growth rate (CAGR) of 14.5%. The growth in the historic period can be attributed to increasing genomic and proteomic research activities, adoption of local computational infrastructure, growing need for complex cellular simulations, rising investment in academic and research institutions, expansion of pharmaceutical R&D programs.

The cell biology cloud computing market size is expected to see rapid growth in the next few years. It will grow to $7.9 billion in 2030 at a compound annual growth rate (CAGR) of 14.7%. The growth in the forecast period can be attributed to growing deployment of hybrid cloud computing models, increasing integration with AI-enabled analysis platforms, rising demand for large-scale simulation and modeling, expansion of biotech and pharmaceutical cloud initiatives, increasing adoption of collaborative research platforms. Major trends in the forecast period include increasing adoption of cloud-based cell biology platforms, rising demand for high-performance computing for simulations, growing integration of data analysis and visualization tools, expansion of workflow management and collaboration software, rising focus on personalized medicine and drug discovery applications.

The increasing adoption of personalized and precision medicine is expected to fuel the growth of the cell biology cloud computing market over the forecast period. Personalized and precision medicine involves customizing treatments based on an individual’s genetic, molecular, environmental, and lifestyle factors to enhance therapeutic effectiveness and patient outcomes. The rising implementation of these strategies is largely fueled by their ability to deliver more targeted therapies, minimize adverse effects, and achieve higher clinical success rates compared with traditional treatments. Cell biology cloud computing platforms facilitate personalized and precision medicine by allowing researchers and clinicians to examine complex cellular and molecular processes using scalable, high-performance computational tools. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based nonprofit advocacy organization, the US Food and Drug Administration approved 16 new personalized treatments for rare diseases, up from six in 2022. Therefore, the increasing uptake of personalized and precision medicine is driving the growth of the cell biology cloud computing market.

Key companies operating in the cell biology cloud computing market are focusing on developing advanced solutions, such as AI-driven cloud platforms for high-throughput cell morphology analysis, to enhance data processing efficiency, accelerate research, and improve experimental reproducibility. AI-driven cell biology cloud platforms refer to cloud-based systems that leverage artificial intelligence to automatically analyze cellular imaging data, quantify morphological features, and integrate results with bioinformatics pipelines. For example, in January 2023, ThinkCyte, a Japan-based biotechnology company, unveiled MorphoScan Cloud, a versatile cloud-based platform for AI-driven cell morphology data analysis. This new solution focuses on providing scalable, high-speed analysis of large cellular datasets, which helps researchers accelerate drug discovery, improve phenotypic screening, and optimize experimental design without extensive local computing infrastructure. By leveraging advanced machine learning models and cloud computing resources, the platform enables real-time data processing, collaborative research, and automated reporting. It is engineered to support demanding laboratory and research environments, ensuring consistent, accurate, and scalable performance for cell biology studies, high-content screening, and translational research initiatives.

In August 2023, Ginkgo Bioworks Holdings, Inc., a US-based synthetic biology company specializing in cell programming and biological engineering, collaborated with Google Cloud to develop a next-generation artificial intelligence platform for biological engineering and biosecurity. Through this strategic partnership, Ginkgo designated Google Cloud as its primary cloud provider to accelerate the creation of large-scale machine learning models for genomics and synthetic biology applications. The collaboration aims to facilitate large-scale biological data analysis, advance drug discovery and gene therapy development, and enhance biosecurity capabilities. Google is US-based and provides extensive cloud computing services specifically designed for cell biology, genomics, and life sciences research.

Major companies operating in the cell biology cloud computing market are Siemens AG, Roche Holding AG, Thermo Fisher Scientific Inc, Illumina Inc, QIAGEN Digital Insights, PathAI Inc, LabVantage Solutions Inc, SOPHiA GENETICS SA, Emerald Cloud Lab Inc, Metagenomi Inc, DNAnexus Inc, L7 Informatics Inc, Seqera Labs Inc, Pivot Bio Inc, Genestack Ltd, BioBam Bioinformatics SL, CureMatch Inc, MolecularMatch Inc, Basepair Technologies Inc, and Lamin Labs Inc.

North America was the largest region in the cell biology cloud computing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell biology cloud computing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cell biology cloud computing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cell biology cloud computing market consists of revenues earned by entities by providing services such as simulation services, computational workflow management, cloud-based collaboration, and virtual lab environments. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell biology cloud computing market includes sales of data center racks, cooling systems, and specialized laboratory computers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell biology cloud computing refers to leveraging cloud-based platforms and computational resources to conduct large-scale analysis and simulations of cellular data. It allows researchers to handle complex datasets, perform modeling experiments, and store results efficiently without relying on local infrastructure. This method accelerates scientific discovery by offering scalable, on-demand computing capacity and advanced analytical tools.

The essential components of cell biology cloud computing include software, hardware, and services. Software refers to cloud-enabled platforms and computational tools designed to manage, analyze, and visualize complex cell biology datasets, facilitating collaboration and accelerating scientific discovery. These solutions are deployed through public cloud, private cloud, and hybrid cloud models. They are applied across research, drug discovery, diagnostics, personalized medicine, and other applications, serving end users including pharmaceutical companies, biotechnology firms, academic and research institutions, healthcare institutions, and contract research organizations.

Tariffs on imported high-performance computing hardware, servers, storage devices, and networking equipment are impacting the cell biology cloud computing market by raising acquisition and operational costs, particularly affecting software-hardware integrated platforms and private cloud deployments. Regions such as North America, Europe, and Asia-Pacific that rely heavily on imported computational infrastructure are most affected. While tariffs increase costs, they also encourage local hardware production, foster innovation in energy-efficient computing solutions, and strengthen domestic cloud service capabilities, providing long-term market benefits.

The cell biology cloud computing market research report is one of a series of new reports that provides cell biology cloud computing market statistics, including cell biology cloud computing industry global market size, regional shares, competitors with a cell biology cloud computing market share, detailed cell biology cloud computing market segments, market trends and opportunities, and any further data you may need to thrive in the cell biology cloud computing industry. This cell biology cloud computing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

This product will be delivered within 1-3 business days.